Aspen Aerogels Q3 net loss widens on incident-related costs

By Reuters News


Overview

  • US sustainability solutions firm's Q3 2026 revenue rose 17% yr/yr, exceeding high end of outlook

  • Adjusted EBITDA for Q3 2026 was above the high end of company outlook

  • Net loss widened due to incident-related costs and asset write-down


Outlook

  • Aspen Aerogels expects Q4 2026 revenue between $60 mln and $75 mln

  • Company forecasts Q4 2026 net loss between $11 mln and $8 mln

  • Aspen Aerogels sees Q4 2026 adjusted EBITDA between $5 mln and $13 mln


Result Drivers

  • ENERGY INDUSTRIAL DELIVERIES - Co said robust Energy Industrial segment deliveries contributed to Q3 growth

  • EUROPEAN OEM DEMAND - Record European OEM revenue in Thermal Barrier segment drove growth, per co

  • NEW MARKET ENTRY - Initial Energy Industrial order for data center infrastructure project opened new market opportunity


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Loss Per Share

$0.13

Q3 Net Loss

$10.4 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 1 "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the specialty chemicals peer group is "buy"

  • Wall Street's median 12-month price target for Aspen Aerogels, Inc. is $7.75, about 61.5% above its November 4 closing price of $4.80


Reuters Recommended Reads

  • Nov 3 - EnPro beats Q3 sales, profit estimates on semiconductor demand, outlook raised

  • Nov 3 - AMETEK Q3 sales beat estimates, raises outlook

  • Nov 3 - Mayville Engineering Q3 revenue beats on Datacenter & Critical Power demand


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.